Qilian International Holding Group Stock Forecast, Price & News

-0.05 (-1.99%)
(As of 01/14/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
3,410 shs
Average Volume
16,810 shs
Market Capitalization
$87.95 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive QLI News and Ratings via Email

Sign-up to receive the latest news and ratings for Qilian International Holding Group and its competitors with MarketBeat's FREE daily newsletter.

Qilian International Holding Group logo

About Qilian International Holding Group

Qilian International Holding Group Limited engages in the research, development, and production of active pharmaceutical ingredients (APIs) and traditional Chinese medicine derivative (TCMD) products in China. The company offers licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It also provides Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and sausage casings comprising Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil's chemical properties, and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. The company was incorporated in 2019 and is based in Jiuquan, the People's Republic of China.


See More Headlines

Industry, Sector and Symbol

Pharmaceutical preparations
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$50.03 million


Pretax Margin




Free Float
Market Cap
$87.95 million
Not Optionable

Company Calendar

Next Earnings (Estimated)
Fiscal Year End


Overall MarketRank

1.00 out of 5 stars

Medical Sector

1265th out of 1,417 stocks

Pharmaceutical Preparations Industry

608th out of 683 stocks

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Qilian International Holding Group (NASDAQ:QLI) Frequently Asked Questions

Is Qilian International Holding Group a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Qilian International Holding Group in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Qilian International Holding Group stock.
View analyst ratings for Qilian International Holding Group
or view top-rated stocks.

Are investors shorting Qilian International Holding Group?

Qilian International Holding Group saw a increase in short interest in the month of December. As of December 31st, there was short interest totaling 22,300 shares, an increase of 78.4% from the December 15th total of 12,500 shares. Based on an average trading volume of 20,700 shares, the days-to-cover ratio is presently 1.1 days.
View Qilian International Holding Group's Short Interest

When is Qilian International Holding Group's next earnings date?

Qilian International Holding Group is scheduled to release its next quarterly earnings announcement on Thursday, February 10th 2022.
View our earnings forecast for Qilian International Holding Group

Who are Qilian International Holding Group's key executives?

Qilian International Holding Group's management team includes the following people:
  • Mr. Zhanchang Xin, Chairman, Pres & CEO (Age 54, Pay $17.94k)
  • Ms. Haiping Shi, CFO & Director (Age 48, Pay $14.58k)

When did Qilian International Holding Group IPO?

(QLI) raised $30 million in an initial public offering on Tuesday, January 12th 2021. The company issued 5,000,000 shares at a price of $5.00-$7.00 per share. Univest Securities served as the underwriter for the IPO and Loop Capital Markets was co-manager.

What is Qilian International Holding Group's stock symbol?

Qilian International Holding Group trades on the NASDAQ under the ticker symbol "QLI."

How do I buy shares of Qilian International Holding Group?

Shares of QLI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Qilian International Holding Group's stock price today?

One share of QLI stock can currently be purchased for approximately $2.46.

How much money does Qilian International Holding Group make?

Qilian International Holding Group has a market capitalization of $87.95 million and generates $50.03 million in revenue each year.

How many employees does Qilian International Holding Group have?

Qilian International Holding Group employs 292 workers across the globe.

What is Qilian International Holding Group's official website?

The official website for Qilian International Holding Group is

Where are Qilian International Holding Group's headquarters?

Qilian International Holding Group is headquartered at JIUQUAN ECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE, JIUQUAN F4, 735000.

How can I contact Qilian International Holding Group?

Qilian International Holding Group's mailing address is JIUQUAN ECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE, JIUQUAN F4, 735000. The company can be reached via phone at 86-093-7268-9523 or via email at [email protected].

This page was last updated on 1/17/2022 by Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.